Taiwan Archives

Neuchips Raises $20M in Series B2 Funding

Neuchips, a Los Altos, CA- and Taipei, Taiwan-based provider of an AI ASIC platforms for deep learning recommendation, raised $20M in Series B2 funding.

PressPlay Closes Series B Funding

PressPlay, a Taipei, Taiwan-based influence economy group, closed a Series B funding of undisclosed amount.

Aesop Technology Raises $2.95M in Pre-Series A Funding

Aesop Technology, a Taiwan and US-based digital health startup, raised $2.95M in Pre-Series A funding.

TXOne Networks Raises $70M in Series B Funding

TXOne Networks, an Irving, TX and Taipei, Taiwan-based industrial Internet of Things (IIoT) security solutions provider, raised $70M in Series B funding.

Wavenet Raises Nearly USD$3M in Series B Funding Round

Wavenet, a Taipei-based company which specializes in marketing technology, raised nearly USD$3m in Series B funding.

Shypyard Raises $3M in Funding

Shypyard, a New York City and Taipei-based provider of business planning products and services for brands and direct-to-consumer merchants, raised $3M in funding.

Our Happy Company Raises $7.5M in Seed Funding

Our Happy Company, a Los Angeles, CA- Taipei and Singapore-based provider of a blockchain technology, raised $7.5M in Seed funding.

Hahow Raises US$10M in Series B Funding

Hahow, a Taipei, Taiwan-based online learning platform providing courses across diverse media formats, raised US$10M in Series B funding.

Matters Lab Raises US$2M in Pre-A Funding

Matters Lab, a Hong Kong and Los Angeles-based provider of a Web3 social media platform, raised US$2M in Pre-A funding.

XY Finance Raises $12M in Funding

XY Finance, a Taiwan-based blockchain startup, closed a $12M funding round.

ProLogium Technology Raises US$326M in Funding

ProLogium Technology, a Taipei, Taiwan-based solid-state battery (SSB) company, raised US$326M in funding.

Elixiron Immunotherapeutics Closes $27M Series A-1 Financing Round

Elixiron Immunotherapeutics, Inc., a company developing therapeutics for cancer, neurological diseases and inflammatory disorders, closed a $27m Series A-1 extension financing round, bringing the total Series A-1 raise to $27m.